Conference Coverage Intelligence of Asthma and COPD assets across the Respiratory Therapy area

Case Study of the Assessment of Asthma and COPD assets
Scope & Objective:

A mid-sized European Pharmaceutical Company, wanted DelveInsight to support them by providing a detailed ATS 2022 conference coverage of the assets of their interest in the Asthma and COPD disease area, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.

Congress Coverage Support:
  • DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the Asthma & COPD drugs of their interest.
  • In addition to this DelveInsight also conducted primary research in order to cater the KOL and Stakeholder insights around the emerging drugs
  • High-priority sessions were selected for more focused live coverage
Congress Plan:
  • The team extracted and classified sessions by priorities
  • Captured detail presentation and understand the business insights
  • KITs and KIQs were aligned with the client’s strategic needs
  • The deliverables enabled the client with the proactive response to competitor activities in the Asthma & COPD disease area, and also in the ATS 2022
  • Senior internal stakeholders were timely informed for the latest business updates

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.